Ottobock not only develops innovative products but also takes care of the full treatment cycle. These services are provided under the Ottobock SE & Co. KGaA name, which also began in 2018 to channel the company’s 100-year history of med-tech expertise into sustainably healthy workplaces.
We continually develop our company and perfect our technology to improve the lives of our users. In 2018, we invested 6,5% of our turnover in research and development.
Since 1919 products and technologies from Ottobock have been helping people gain new freedom of movement and avoid potential complications. Initially, the company revolutionised the market – above all treatment for patients – thanks to the series production of prosthetic components. Since then, the focus has turned to microprocessor-controlled knee joints such as the C-Leg (which can be controlled via an app), the computer-controlled C-Brace leg orthosis, the multi-articulating bebionic hand, Juvo power wheelchairs and the Paexo exoskeleton range for ergonomic workplaces.
Our single-minded determination to improve quality of life has made us a global leader in technology for wearable human bionics, which enhance or replace parts of the human body.